Novartis Pharmaceuticals Canada Inc.
Novartis Pharmaceuticals Canada Inc., a subsidiary of the global healthcare leader Novartis AG, is headquartered in Canada and operates extensively across the country. Founded in 1996, the company has established itself as a key player in the pharmaceutical industry, focusing on innovative medicines and advanced therapies in areas such as oncology, cardiology, and immunology. With a commitment to research and development, Novartis Canada has introduced several groundbreaking treatments that address unmet medical needs, setting them apart in a competitive market. Their portfolio includes unique biologics and targeted therapies that have significantly improved patient outcomes. Recognised for its contributions to healthcare, Novartis holds a strong market position, consistently ranking among the top pharmaceutical companies in Canada.
DitchCarbon Score
How does Novartis Pharmaceuticals Canada Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novartis Pharmaceuticals Canada Inc.'s score of 65 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novartis Pharmaceuticals Canada Inc.'s reported carbon emissions
Novartis Pharmaceuticals Canada Inc. currently does not have available carbon emissions data for the most recent year, nor are there specific reduction targets or initiatives documented. Without concrete figures or commitments, it is challenging to assess their climate impact or progress in reducing carbon emissions. However, as a major player in the pharmaceutical industry, Novartis is expected to align with industry standards and best practices regarding climate commitments. The company may be involved in broader corporate sustainability efforts, but specific details on their carbon emissions and climate strategies are not provided.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Novartis Pharmaceuticals Canada Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
